共 368 条
[1]
Weissmann G(2006)The pathogenesis of rheumatoid arthritis Bull NYU Hosp Jt Dis 64 12-15
[2]
Joseph A(2010)Immunologic rheumatic disorders J Allergy Clin Immunol 125 204-215
[3]
Brasington R(2011)Annual Drug Update 2010 in review Nurse Pract 36 10-22
[4]
Kahl L(2011)Leflunomide or methotrexate? Comparison of clinical efficacy and safety in low socio-economic rheumatoid arthritis patients Mod Rheumatol 21 375-380
[5]
Ranganathan P(2010)Updated consensus statement on biological agents for the treatment of rheumatic diseases Ann Rheum Dis 69 2-29
[6]
Cheng TP(2011)Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort Ann Rheum Dis 70 611-615
[7]
Atkinson J(1995)Modified disease activity scores that include twenty eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 44-48
[8]
Belavic JM(2006)Remission of rheumatoid arthritis: should we care about definitions? Clin Exp Rheumatol 24 45-51
[9]
Ishaq M(2007)Updates on high throughput molecular profiling for the study of rheumatoid arthritis J Cell Physiol 213 626-634
[10]
Muhammad JS(2008)The importance of reporting disease activity states in rheumatoid arthritis clinical trials Arthritis Rheum 58 2622-2631